Emperor Metals reported strong gold drill results at Duquesne West, including 7.0 g/t over 24.8 meters near surface, enhancing the project's economic potential. The 2026 program involved over 20,000 meters of drilling and historic core resampling, with more drilling planned to refine the resource model. These results support advancing toward a new mineral resource estimate and preliminary economic assessment soon. The findings highlight thicker, higher-grade zones and free gold, boosting exploration and development prospects.
The Duquesne West gold project is the subject, with Pluang market data providing context. On November 4, 2026, out of 150 priced US stocks on Pluang, 121 rose and 27 fell. Notable movers include Barclays PLC (BCS) at USD 23.60 with a 5.36% increase and 100% sell order activity, Tesla (TSLA) at USD 379.80 down 4.69%, and Palantir Technologies (PLTR) at USD 167.20 down 4.68%, as of 20:21 WIB.
Goldman Sachs Group, Inc. disclosed that it briefly held a combined stake exceeding 3% in Ontex Group NV shares as of October 27, 2026, with 566,115 voting rights and 1,965,157 financial instruments. However, by October 28, 2026, their combined posit...
BNP Paribas announced its monthly declaration of voting rights and shares as of October 31, 2026. The bank reported a total of 1,101,600,607 shares and an equal number of voting rights. This update is part of regulatory compliance under French commer...
Ontex disclosed that Goldman Sachs Group, Inc. crossed the 3% ownership threshold in Ontex shares on October 27, 2026, holding a combined total of 3.07% including voting rights and financial instruments. However, the next day, October 28, 2026, Goldm...
Neion Bio has appointed John A. Maga, Ph.D., as Head of Biologics and CMC to lead the development of biologic medicines using its Raptor platform, which produces proteins in transgenic chicken eggs. Maga brings over 25 years of biopharmaceutical expe...
The National Advertising Division (NAD) recommended that Good Life Meds discontinue claims about health benefits and personalization for its compounded Tirzepatide+ weight loss products after a challenge by Eli Lilly. NAD found that Good Life lacked ...
